Analyte monitoring devices and methods

Information

  • Patent Grant
  • 11213226
  • Patent Number
    11,213,226
  • Date Filed
    Thursday, October 6, 2011
    12 years ago
  • Date Issued
    Tuesday, January 4, 2022
    2 years ago
Abstract
Methods and devices for providing application specific integrated circuit architecture for a two electrode analyte sensor or a three electrode analyte sensor are provided. Systems and kits employing the same are also provided.
Description
BACKGROUND

The detection and/or monitoring of glucose levels or other analytes, such as lactate, oxygen, A1C, or the like, in certain individuals is vitally important to their health. For example, the monitoring of glucose is particularly important to individuals with diabetes. Diabetics generally monitor glucose levels to determine if their glucose levels are being maintained within a clinically safe range, and may also use this information to determine if and/or when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.


Growing clinical data demonstrates a strong correlation between the frequency of glucose monitoring and glycemic control. Despite such correlation, many individuals diagnosed with diabetic condition do not monitor their glucose levels as frequently as they should due to a combination of factors including convenience, testing discretion, pain associated with glucose testing, and/or cost.


Devices have been developed for the automatic or continuous monitoring of analyte(s), such as glucose, in bodily fluid such as in the blood stream or in interstitial fluid (“ISF”), or other biological fluid. Some of these analyte measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user, so that the monitoring is accomplished in vivo.


With the continued development of analyte monitoring devices and systems, there is a need for such analyte monitoring devices, systems, and methods, as well as for processes for manufacturing analyte monitoring devices and systems that are cost effective, convenient, and with reduced pain, provide discreet monitoring to encourage frequent analyte monitoring to improve glycemic control.


INCORPORATION BY REFERENCE

Patents, applications and/or publications described herein, including the following patents, applications and/or publications are incorporated herein by reference for all purposes: U.S. Pat. Nos. 4,545,382, 4,711,245, 5,262,035, 5,262,305, 5,264,104, 5,320,715, 5,356,786, 5,509,410, 5,543,326, 5,593,852, 5,601,435, 5,628,890, 5,820,551, 5,822,715, 5,899,855, 5,918,603, 6,071,391, 6,103,033, 6,120,676, 6,121,009, 6,134,461, 6,143,164, 6,144,837, 6,161,095, 6,175,752, 6,270,455, 6,284,478, 6,299,757, 6,338,790, 6,377,894, 6,461,496, 6,503,381, 6,514,460, 6,514,718, 6,540,891, 6,560,471, 6,579,690, 6,591,125, 6,592,745, 6,600,997, 6,605,200, 6,605,201, 6,616,819, 6,618,934, 6,650,471, 6,654,625, 6,676,816, 6,730,200, 6,736,957, 6,746,582, 6,749,740, 6,764,581, 6,773,671, 6,881,551, 6,893,545, 6,932,892, 6,932,894, 6,942,518, 7,041,468, 7,167,818, 7,299,082, and 7,866,026, U.S. Patent Publication Nos. 2004/0186365, 2005/0182306, 2006/0025662, 2006/0091006, 2007/0056858, 2007/0068807, 2007/0095661, 2007/0108048, 2007/0199818, 2007/0227911, 2007/0233013, 2008/0066305, 2008/0081977, 2008/0102441, 2008/0148873, 2008/0161666, 2008/0267823, 2009/0054748, 2009/0294277, 2010/0213057, 2010/0081909, 2009/0247857, 2011/0106126, 2011/0082484, 2010/0326842, 2010/0198034, 2010/0324392, 2010/0230285, 2010/0313105, 2011/0213225, 2011/0021889, 2011/0193704, 2011/0190603, and 2011/0191044, U.S. patent application Ser. Nos. 13/071,461, 13/071,487, and 13/071,497, and U.S. Provisional Application No. 61/325,260.


SUMMARY

In view of the foregoing, devices, methods and systems for providing electronics for coupling to analyte sensors are provided including, for example, application specific integrated circuit (ASIC) configurations that provide electrical coupling of electrodes of analyte sensors having one or more configurations such as, for example, self powered two electrode analyte sensors, or three electrode analyte sensors.


Embodiments of the present disclosure include analyte monitoring devices. Certain aspects of analyte monitoring devices comprise an analyte sensor including a plurality of electrodes, including an in vivo portion of the analyte sensor configured for fluid contact with a bodily fluid under a skin layer, the analyte sensor configured to monitor an analyte level in the bodily fluid and to generate one or more signals associated with the monitored analyte level and sensor electronics including a sensor interface section and a data processing section, the sensor interface section configured to electrically couple to the plurality of electrodes of the analyte sensor, and the data processing section configured to process one or more signals received from the analyte sensor, wherein the sensor interface section includes an electrical interface to couple to two electrodes of the plurality of electrodes, or three electrodes of the plurality of electrodes, and further wherein the data processing section includes an application specific integrated circuit with programmable logic to perform one or more operations of the data processing section including processing the one or more signals from the analyte sensor for filtering, calibration, storage, transmission, or one or more combinations thereof.


Certain embodiments include providing an analyte sensor including a plurality of electrodes, including an in vivo portion of the analyte sensor for fluid contact with a bodily fluid under a skin layer, the analyte sensor for monitoring an analyte level in the bodily fluid and for generating one or more signals associated with the monitored analyte level and providing sensor electronics including a sensor interface section and a data processing section, wherein providing sensor electronics includes configuring the sensor interface section to electrically couple to the plurality of electrodes of the analyte sensor, and configuring the data processing section to process one or more signals received from the analyte sensor, wherein configuring the sensor interface section includes providing an electrical interface to couple to two electrodes of the plurality of electrodes, or three electrodes of the plurality of electrodes and further wherein configuring the data processing section includes providing an application specific integrated circuit with programmable logic to perform one or more operations of the data processing section including processing the one or more signals from the analyte sensor for filtering, calibration, storage, transmission, or one or more combinations thereof.


These and other objects, features and advantages of the present disclosure will become more fully apparent from the following detailed description of the embodiments, the appended claims and the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows an overall in vivo sensor based analyte monitoring system for use in certain embodiments of the present disclosure;



FIG. 2 illustrates a block diagram of the on body electronics configured for operation with a two electrode analyte sensor in certain embodiments;



FIG. 3 illustrates a block diagram of the on body electronics configured for operation with a two electrode analyte sensor with a power source in certain embodiments;



FIG. 4 illustrates a block diagram of the on body electronics configured for operation with a two electrode sensor or a three electrode analyte sensor in certain embodiments; and



FIGS. 5 and 6 are graphical illustrations of thermistor characteristics for use in the analyte monitoring system of FIG. 1 in certain embodiments.





DETAILED DESCRIPTION

Before the present disclosure is described in detail, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.


Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges is also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.


It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.


The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.


As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.


The figures shown herein are not necessarily drawn to scale, with some components and features being exaggerated for clarity.



FIG. 1 shows an exemplary in vivo based analyte monitoring system 100 in accordance with embodiments of the present disclosure. As shown, in certain embodiments, analyte monitoring system 100 includes on body electronics 110 electrically coupled to in vivo analyte sensor 101 (a proximal portion of which is shown in FIG. 1) and attached to adhesive layer 140 for attachment on a skin surface on the body of a user. On body electronics 110 includes on body housing 119, that defines an interior compartment. Also shown in FIG. 1 is insertion device 150 that, when operated, transcutaneously positions a portion of analyte sensor 101 through a skin surface and in fluid contact with ISF, and positions on body electronics 110 and adhesive layer 140 on a skin surface. In certain embodiments, on body electronics 110, analyte sensor 101 and adhesive layer 140 are sealed within the housing of insertion device 150 before use, and in certain embodiments, adhesive layer 140 is also sealed within the housing or itself provides a terminal seal of the insertion device 150. Devices, systems and methods that may be used with embodiments herein are described, e.g., in U.S. Patent Publication Nos. 2010/0198034, 2010/0324392 and 2011/0213225, the disclosures of each of which are incorporated herein by reference for all purposes.


Referring back to the FIG. 1, analyte monitoring system 100 includes display device 120 which includes a display 122 to output information to the user, an input component 121 such as a button, actuator, a touch sensitive switch, a capacitive switch, pressure sensitive switch, jog wheel or the like, to input data or command to display device 120 or otherwise control the operation of display device 120.


In certain embodiments, input component 121 of display device 120 may include a microphone and display device 120 may include software configured to analyze audio input received from the microphone, such that functions and operation of the display device 120 may be controlled by voice commands. Display device 120 also includes data communication port 123 for wired data communication with external devices such as remote terminal (personal computer) 170, for example. Display device 120 may also include an integrated in vitro glucose meter, including in vitro test strip port 124 to receive an in vitro glucose test strip for performing in vitro blood glucose measurements.


Referring still to FIG. 1, display 122 in certain embodiments is configured to display a variety of information—some or all of which may be displayed at the same or different time on display 122. Display 122 may include but is not limited to graphical display 138, numerical display 132, trend or directional arrow display 131, date display 135, time of day information display 139, battery level indicator display 133, sensor calibration status icon display 134, and wireless connectivity status icon display 137 that provides indication of wireless communication connection with other devices such as on body electronics, data processing module 160, and/or remote terminal 170. As additionally shown in FIG. 1, display 122 may further include simulated touch screen button 125, 126 for accessing menus, changing display graph output configurations or otherwise for controlling the operation of display device 120.


Further details and other display embodiments can be found in, e.g., U.S. Patent Publication Nos. 2011/0193704 and 2011/0213225, the disclosures of each of which are incorporated herein by reference for all purposes.


After the positioning of on body electronics 110 on the skin surface and analyte sensor 101 in vivo to establish fluid contact with ISF (or other appropriate body fluid), on body electronics 110 in certain embodiments is configured to wirelessly communicate analyte related data (such as, for example, data corresponding to monitored analyte level and/or monitored temperature data, and/or stored historical analyte related data) when on body electronics 110 receives a command or request signal from display device 120. In certain embodiments, data from on body electronics 110 is retrieved using display device 120 or a reader via a wireless link that operates using a near field reflective communication technique such as used in radio frequency identification (RFID) system. Using such systems, in certain embodiments, analyte measurement from analyte sensor 101 can be obtained by positioning the display device 120 within a short range of the on body electronics 110, and optionally actuating a button such as input component 121.


In certain embodiments, the RFID communication operates at a nominal operating frequency of 13.56 MHz, with minimum antenna input voltage for normal operation at about 2.5 Volts. Data rate for transmit and receive between on body electronics 110 and display device 120 may be about 20-30 kbits/second, or about 22-28 kbits/second, or about 26.48 kbits/second (data bits) in certain embodiments. Within the scope of the present disclosure, other operating frequencies for RFID communication as well as other parameters such as data transmission rates, and/or antenna input voltages are contemplated.


In certain embodiments, on body electronics 110 may be configured to at least periodically broadcast real time data associated with monitored analyte level which is received by display device 120 when display device 120 is within communication range of the data broadcast from on body electronics 110, i.e., it does not need a command or request from a display device to send information.


In certain embodiments, the received data from the on body electronics 110 may be stored (permanently or temporarily) in one or more memory of the display device 120. Referring still to FIG. 1, also shown in analyte monitoring system 100 are data processing module 160 and remote terminal 170. Remote terminal 170 may include a personal computer, a server terminal a laptop computer or other suitable data processing devices including software for data management and analysis and communication with the components in the analyte monitoring system 100.


Data processing module 160 may include components to communicate using one or more wireless communication protocols such as, for example, but not limited to, infrared (IR) protocol, BLUETOOTH® protocol, ZIGBEE® protocol, and 802.11 wireless LAN protocol. Additional description of communication protocols including those based on BLUETOOTH® protocol and/or ZIGBEE® protocol can be found in U.S. Patent Publication No. 2006/0193375 incorporated herein by reference for all purposes.


In a further aspect, software algorithms for execution by data processing module 160 may be provided to a communication device such as a mobile telephone including, for example, WiFi or Internet enabled smart phones or personal digital assistants (PDAs) as a downloadable application for execution by the downloading communication device. Additional details describing field upgradability of software of portable electronic devices, and data processing are provided in U.S. Patent Publication Nos. 2010/0198034, 2010/0313105, 2010/0198142, 2010/0204557 and 2011/0126188, and U.S. Provisional Application No. 61/325,155 the disclosures of each of which are incorporated by reference herein for all purposes.



FIG. 2 illustrates a block diagram of the on body electronics configured for operation with a two electrode analyte sensor in certain embodiments.


In certain embodiments, sensor 210 is inserted under the skin into the interstitial fluid of a user, and responds to changes in glucose concentration. The sensor 210 is a two terminal device including working electrode 211 and counter electrode 212 that can be electrically modeled as a current source which generates a current signal as a function of the detected or monitored glucose concentration. The sensor 210 output may be dependent on temperature. In certain embodiments, a high-value resistor is connected across the sensor terminals 211, 212 and may be part of the sensor assembly. In certain embodiments, sensor 210 is a self generating, self powered sensor and does not require a bias potential applied from an external power source. In certain embodiments, the sensor output may vary up to about 400 millivolts over the full range of glucose and temperature monitored and/or detected. Further detail of sensor 210 is provided in U.S. Patent Publication No. 2010/0213057 and U.S. Provisional Application No. 61/325,260, the disclosures of each of which are incorporated herein by reference.


Referring to FIG. 2, in certain embodiments, sensor 210 is operatively coupled to resistors 215a, 215b as shown whose terminals respectively are coupled to capacitors 216a, 216b. In certain embodiments, resistors 215a, 215b may include 2.5 MΩ resistors, while capacitors 216a, 216b may include 100 μFarad, 1 μFarad capacitors, respectively. Thermistor or other resistance temperature device (RTD) 282 and reference resistor 283 are provided as shown and coupled to ASIC 220.


In certain embodiments, upon initialization of sensor 210, reference resistance R is measured once and the measured resistance is stored (for example, in a memory device provided on ASIC 220). After measuring the reference resistance R, in certain embodiments, the resistance is measured or detected based on the measurement from the thermistor or RTD 282.


Referring to FIG. 2, in certain embodiments, ASIC 220 is powered by a magnetic field generated by the display device 120 (FIG. 1). As described above, the sensor interface in certain embodiments includes a network of two resistors 215a, 215b and two capacitors 216a, 216b across sensor electrodes 211, 212. In certain embodiments, ASIC 220 is configured to sample two voltages from this sensor network for each analyte measurement acquisition. In a steady-state, both differential voltages from the sensor network will be at similar in level and range from about 0 to 200 mV. Also shown in FIG. 2 is temperature detection circuit 280 coupled to 12 bit A/D converter 222 of ASIC 220 via analog multiplexer 221. The temperature detection circuit 280 includes current source 281, an external thermistor 282 and corresponding switch 284 and reference resistor 283 and corresponding switch 285. In certain embodiments, current source 281 includes one or more of a physical current source such as a resistor current source (e.g., a voltage source), an active current source (e.g., a transistor current source), or an inductor type current source (e.g., using a voltage regulator).


More specifically, in certain embodiments, ASIC 220 includes an internal band-gap temperature sensor 225 (e.g., having a forward voltage of a diode that is temperature dependent) with a predetermined level of or controlled slope variation (e.g., with a minimum tolerance threshold) from ASIC component to ASIC component during manufacturing, and the temperature sensor calibration may be achieved with a single point temperature calibration with, for example, a predetermined an offset error. Also shown in ASIC 220 are analog multiplexer 221 that interfaces with the sensor electrodes 211, 212, and is operatively coupled to 12-bit A.D converter 222, which in certain embodiments, may be controlled based at least in part on logic from state machine 223. In certain embodiments, ASIC 220 may include a processor, such as a reduced instruction set computing (RISC) processor or other processing unit containing programming to implement the logic of ASIC 220 in lieu of state machine 223.


In certain embodiments, to protect the integrity of the A/D conversion (such as, for example, to minimize undesirable noise affecting the A/D conversion), display device 120 (FIG. 1) may be configured to disable RF communication during the A/D conversion process. An external capacitor (not shown) of a few hundred nano Farads may be provided to store sufficient charge to power the A/D converter, based for example, upon logic implemented by state machine 223, in the absence of RF power from display device 120.


Referring still to FIG. 2, in certain embodiments, RF power is provided to the ASIC via the antenna 240 and RFID 224 and power 226 sections of the ASIC 220. When RF power is presented or within the range of antenna 240 and a predetermined RF command is received (for example, from display device 120), ASIC 220 may be configured to perform four A/D conversions—two conversions from the sensor 210 and two for the temperature measurement—and also, to store the raw A/D values in ASIC memory to be retrieved by display device 120. This routine in certain embodiments comprises one complete analyte measurement acquisition.



FIG. 3 illustrates a block diagram of the on body electronics configured for operation with a two electrode analyte sensor with a power source in certain embodiments. Referring to FIG. 3, in the embodiment shown, battery 350 is provided with a switch 329 to allow for ASIC 320 to perform analyte level measurements with sensor 210 autonomously, and to be retrieved at a later time by display device 120 (FIG. 1). More specifically, the embodiment of ASIC 320 shown in FIG. 3 (compared to the embodiment shown in FIG. 2) includes charge pump 327 with capacitor 335 operatively coupled to the state machine 323, configured to convert the 1.5 Volts from battery 350 to about 3 Volts needed by ASIC 320 analog front-end circuitry for the measurement circuit. Also included in ASIC 320 is timer 328 which is a free-running timer clock providing a time of day information. In certain embodiments, a crystal oscillator 326 and resistor 334 may be provided.


Additionally, ASIC 320 may include extra memory for storage of measurement data, and battery isolation switch for long-term shelf life. Battery 350 may be configured to make analyte measurements without the RF power applied from display device 120 (FIG. 1). In this manner, only one differential voltage may need to be sampled between working electrode 211 and counter electrode 212 (coupled to resistor 315 (e.g., 5 MΩ) and capacitor 316 (e.g., 1 μFarad)) for each monitored analyte measurement.


In certain embodiments, analyte level trend information may be determined by display device 120 (FIG. 1) based on a pre-determined number of analyte measurements retained by ASIC 320. ASIC 320 in certain embodiments may measure each sample spaced at a pre-determined time interval and store each measurement in the ASIC memory. The oldest of the samples may be overwritten with each new sample taken. The retained data may be available to determine analyte level trend. Additionally, ASIC 320 may be configured to capture a pre-determined number of sensor and temperature samples spaced further apart for historical data logging for a total of about 8 hours. Within the scope of the present disclosure other suitable time periods may be used for historical data logging, such as 1 hour, 3 hours, 6 hours, 12 hours, 24 hours, 3 days, 5 days, 10 days, 14 days or more.


In certain embodiments, to provide sufficient time accuracy over an 8 hour period, for example (or other time periods), the internal clock of ASIC 320 may be configured to be as accurate to at least +/−3%. The accuracy may be improved or assisted by an external precision resistor.


Referring again to FIG. 3, battery isolation switch 329 may be configured to preserve the battery life during long-term inventory storage or increase the shelf life of battery 350. ASIC 320 in certain embodiments may be configured to activate battery isolation switch 329 upon receipt of a qualified or predetermined RF message or command from display device 120. Thus, the RFID portion 324 of the ASIC 320 may be configured to operate under RF power. Additional description of RF command or close proximity communication is provided in U.S. Pat. No. 7,826,382, the disclosure of which is incorporated herein by reference.


Further, as discussed above, internal band-gap temperature sensor 325 in certain embodiments includes a predetermined level of controlled slope variation (e.g., with a minimum tolerance threshold) from ASIC component to ASIC component during manufacturing, and the temperature sensor calibration may be achieved with a single point temperature calibration with, for example, a predetermined offset error. Provided below is a table illustrating exemplary, non limiting parameters and associated values for the embodiment shown in FIG. 3. While specific ranges and/or values are shown below, within the scope of the present disclosure, other ranges and/or values are contemplated.














Item
Parameter
Value







1
Charge pump input voltage range
1.2 V to 1.8 V


2
External capacitance for charge pump
2 uF max.


3
Battery switch off-mode leakage
20 nA max.


4
Clock timer frequency accuracy (with
+/−5%, from



external precision reference resistor)
5° C.-60° C.


5
Internal memory
800 bytes, volatile or




non-volatile










FIG. 4 illustrates a block diagram of the on body electronics configured for operation with a two electrode sensor or a three electrode analyte sensor in certain embodiments. Referring to FIG. 4, in certain embodiments, ASIC 420 may be configured for use with either a two electrode analyte sensor 410 or a three electrode analyte sensor. In certain embodiments, the two electrode sensor may include a working electrode (WRK) 411 and a reference electrode (REF) 412, while the three electrode sensor additionally includes a counter electrode (CNTR) 413. Referring still to FIG. 4, the sensor, whether a two electrode or a three electrode sensor, is coupled to ASIC 420 for operation.


In certain embodiments, the analog front end (AFE) of ASIC 420 includes two amplifiers, U1430 and U2431. As can be seen in FIG. 4, when a two electrode sensor is connected to the ASIC AFE, the inverting input terminal of amplifier U1430 is coupled to the working electrode 411 of the sensor, the non-inverting input terminal of amplifier U1430 is connected to a reference voltage source, and the output terminal of amplifier U1430 is connected to the reference electrode 412, as illustrated by dotted line 402 of FIG. 4. In certain embodiments, a feedback resistor 415, which is a high resistance resistor (e.g., 5 MΩ resistor) and capacitor 416, are provided between the working and reference electrodes 411, 412 respectively. In certain embodiments where the sensor is a two electrode sensor, the connection between amplifier U2431 and sensor 410 is open, such that amplifier U2431 and the circuits shown with dotted line 403 are not connected to the sensor.


In certain embodiments where a three electrode sensor is connected to the ASIC AFE, the inverting input terminal of amplifier U1430 is connected to the working electrode 411 of the sensor, just as in the two electrode sensor embodiments, however, the reference electrode 412 is coupled to the inverting input terminal of amplifier U2431 instead of the output terminal of amplifier U1430. Further, the counter electrode 413 may be coupled to the output terminal of amplifier U2431. In the three electrode sensor embodiments, the connection between reference electrode 412 and amplifier U2431 (dotted line 403) is closed thereby coupling amplifier U2431 to sensor 410, while the connection between the output of amplifier U1430 and the reference electrode 412 (dotted line 402) is open, such that the output of amplifier U1430 is not connected to reference electrode 412 of the sensor.


Similar to the ASIC configuration of FIG. 3, in certain embodiments, ASIC 420 shown in FIG. 4 includes battery 450 provided with switch 429 such that ASIC 420 is configured to process and/or store analyte level measurements from sensor 410 autonomously. ASIC 420 as shown in FIG. 4 also includes charge pump 427 with capacitor 435 operatively coupled to state machine 423. Charge pump 427, in certain embodiments, is configured to convert the 1.5 Volt signal from battery 450 to about 3 Volts for ASIC 420 to operate to acquire, filter, store or otherwise process signals received from the analyte sensor 410. In certain embodiments, ASIC 420 also includes timer 428 which is a free-running timer clock providing a time of day information, crystal oscillator 426 and resistor 434 operatively coupled to crystal oscillator 426.


Referring back to FIGS. 3 and 4, also provided is temperature detection circuit 280 as shown and described in conjunction with FIG. 2 above, and which is coupled to the respective A/D converter 322 of ASIC 320 (FIG. 3), and to A/D converter 422 of ASIC 420 (FIG. 4) via the respective analog multiplexer 321, 421.


In certain embodiments, signals corresponding to monitored analyte levels from the sensor, whether a two electrode sensor or a three electrode sensor, are processed by ASIC 420. Referring to FIG. 4, in certain embodiments, ASIC 420 includes an A/D converter 422 which may be a 15 bit A/D converter. In certain embodiments, the A/D conversion may include a sigma-delta modulator. Sigma-delta modulation may provide other functions in addition to simple A/D conversion, including, but not limited to, adjustable conversion resolution, which may be proportional with the converter modulator clock frequency or acquisition period of the conversion, and signal filtering. Further, a sigma-delta modulator may be configured for low power consumption as a sigma-delta modulator may be configured for use with a low clock rate, utilizing less power. In certain embodiments, utilizing a longer duration acquisition period for the sigma-delta conversion may provide signal filtering of the data signals. Variation in the acquisition period duration may affect the level of signal filtering provided by the sigma-delta modulation.


In the manner described above, the ASIC power source may include a low-power disposable power source, e.g., a battery that may be used for the voltage source for the reference voltage signals for the amplifiers of ASIC 420 and to power the clock and sigma-delta modulator without draining the power source rapidly. In this manner, increased battery life may result and in turn, increased electronics use life can be attained. Further examples and details related to sigma-delta modulation and analog-to-digital conversion can be found in, among others, U.S. Patent Publication No. 2011/0060530, the disclosure of which is incorporated herein by reference for all purposes.


In certain embodiments, the configuration of ASIC 420 may be based on a 0 Volts to 2 Volts input voltage range of the A/D converter 422. In such embodiments, with an analyte sensor that requires a compliance range of about 2 Volts, a 2 Volt voltage source may be provided to the inverting terminal of amplifier U1430, such that the terminal is biased at a fixed 2 Volts. This configuration may be applicable to both the two electrode and the three electrode analyte sensors. In the embodiments where the sensor is a three electrode analyte sensor, the input voltage to the positive terminal of amplifier U2431 may be 1.96V. While specific values are provided for voltages, within the scope of the present disclosure, other voltages and ranges of voltages are contemplated.


For an analyte sensor current range of 0 nA to 85 nA and a feedback resistance of 5 MΩ, the output voltage of amplifier U1430 may change by 0.425V (5,000,000Ω*85 nA), which in turn results in a A/D converter input voltage in the range of 2V-1.575V. In certain embodiments, ASIC clock, which may be provided by timer 428, includes a 32.786 KHz clock and the analyte measurement may be performed over a 30 second time window data acquisition period. In such embodiments, the resulting resolution of the A/D converter is approximately 30,720 counts full scale (approximately 15 bits), and the digital conversion of about 0 Volt to about 2 Volt input voltage range would be from 0 to 30,720 counts.


Referring still to FIG. 4, in certain embodiments, the transimpedance amplifier U1430 may be used to convert sensor current into an output voltage. The range of sensor current that is accommodated include about 0 nA to about 85 nA. Moreover, in certain embodiments, A/D conversion range may include (0.425V/2V)*30,720=6,528 Counts. This provides a resolution of 13 pA. In certain embodiments, a low threshold for sensor sensitivity may be about 11.1 pA/mg/dL resulting in a resolution of about 1.1 mg/dL, for example.


The table below illustrates exemplary, non-limiting parameters and values for the embodiment shown in FIG. 4. As such, within the scope of the present disclosure, other ranges and/or values are contemplated:














Item
Parameter
Value

















1
WRK electrode voltage
2 V +/− 250 mV


2
Poise voltage = WRK − REF
40 mV +/− 25 mV (part




to part variation.)


3
Poise voltage stability
+/−25 mV. This means



(20° C. to 50° C.)
worse case stack up of part to




part variation + temperature




is 40 mV +/− 50 mV.


4
Servo Amplifier output voltage
0.2 to WRK Potential (Volts)


5
Servo Amplifier input leakage
<+/−10 pA (Biased at



current
1.96 V at about 25° C.)


6
Servo Amplifier input offset
+/−10 mV



Voltage



7
Servo Amplifier input offset
+/−75 uV/° C.



drift



8
WRK Amplifier output voltage
1.25 V to WRK Potential +




75 mV.


9
WRK Amplifier input leakage
<+/−20 pA (Biased at



current
about 2 Volts)


10
WRK Amplifier input offset
+/−10 mV



Voltage



11
WRK Amplifier input offset
+/−75 uV/° C.



drift









In certain embodiments, one measurement cycle may include first 30 seconds including glucose data, second 15 seconds temperature thermistor or RTD data, third 15 seconds of internal temperature measurement to result in a total of 60 seconds per measurement cycle.


Table below provides exemplary, non limiting parameters and values for the analyte sensor analog front end electronics in certain embodiments. While specific values and/or ranges of values are shown below, within the scope of the present disclosure other suitable values or ranges of values are contemplated:














Item
Parameter
Value







1
Sensor Measurement Resolution.
12 bits or better for an input



The resolution covers the sensor
operating range of 425 mV.



sensitivity range, accomplishing 2




bits of this resolution with variable




gain in front of the converter.



2
Maximum input leakage current for
<+/−10 pA (measured at



both the condition where the ASIC
100 mV input at about



is powered and also when it is not
25° C.)



powered. (Assumes limited




temperature range from (Specified




25° C. to 40° C.) and limited




voltage input up to 100 mV)



3
Total Measurement Error −
<+/−1.5%



Linearity post calibration error.




(Assumes that offset is calibrated




to +/−1 A/D Count and slope




is calibrated to +/−0.5%




at full scale.)



4
AFE measurement. Thermal drift −
+/−5 A/D Count.



change in offset post calibration.




(Specified 25° C. to 40° C.)



5
AFE measurement. Thermal drift −
+/−1.5%



slope (Specified 25° C. to 40° C.)



6
Electrostatic discharge (ESD)
Achieve +/−2 KV human



Protection
body model (HBM) for each




pin on the ASIC. For low




leakage inputs, use +/−500 V




human body model (HBM).


7
RF interference
Measurement accuracy is




maintained when the display




device is used to acquire




sensor data. Display device




may terminate RF




transmission temporarily




for RF quieting during




measurement.




For the architectures with a




battery, data may be marked




“bad” if measurement




occurs during RF communica-




tion.










FIGS. 5 and 6 are graphical illustrations of thermistor characteristics for use in the analyte monitoring system of FIG. 1 in certain embodiments.


In certain embodiments, the ASIC may also be configured to accommodate two types of temperature sensors in addition to the two or three electrode analyte sensors. In certain embodiments, the temperature sensor is a resistive device, such as a thermistor or a resistive thermal device (RTD), in addition to a reference resistor. The resistive temperature sensor and the reference resistor are both ground referenced with a current source provided by the ASIC, in certain embodiments. In certain embodiments, the current source current is determined based on the desired input voltage range of the A/D converter. This current may be in the 1 pA or 1 mA range, for example. The input voltage range, and thus the current, may be based on the desired resolution of the output of the A/D converter. For example, utilizing a 32.768 KHz ASIC clock and a 15 second temperature detection acquisition window, operating at a 0 Volt to 0.5 Volt input range, the resulting resolution of the temperature sensor would be 0-3,840 counts, or 0.13 mV/count.


In certain embodiments, the sensor has about +7%/° C. dependency. Skin temperature may be measured using a thermistor 282. This method in certain embodiments, includes reference resistor 283 and the measurement thermistor 282 multiplexed into a 12 bit (or other suitable resolution) A/D converter. Excitation of the thermistor 282 and reference resistor 283 may utilize a common 1 μA current source 281.


In certain embodiments, an internal (e.g., internal to ASIC) temperature sensor 225 (FIG. 2), 325 (FIG. 3), 425 (FIG. 4) in addition to the external thermistor interface 280 may be provided. The internal temperature sensor 225, 325, 425 may be used for thermal gradient correction. As discussed above, internal ASIC temperature sensor may be calibrated using a single point temperature calibration. To this end, in certain embodiments, the part-to-part consistency of the slope of the temperature sensor in the ASIC component is maintained within a predetermined threshold range or above a preset level, and further, errors observed during temperature calibration may be attributed to offset errors.


In certain embodiments, the temperature sensor is a resistive device that can be either a thermistor or an RTD in addition to a reference resistor. The reference resistor and resistive temperature sensor are ground referenced and will have a current source excitation provided by the ASIC.


In certain embodiments, current source may be either in the 1 uA or 1 mA range depending on the device selected, and may be designed so that the desired input voltage range to the A/D is met. The input voltage range to the A/D converter in certain embodiments is sized to ensure that the desired resolution is achieved.


In certain embodiments, temperature and reference resistor measurement may be achieved over a 15 second acquisition period and the modulator clock may be 32,768 Hz/32=1,024 Hz and is derived from the ASIC 32.768 KHz clock. The resulting resolution over the operating input range 0V-0.5V may be 1,024*15*0.5/2=3840 counts or 0.13 mV/count. For a change from 40° C. to 41° C., the thermistor resistance changes by 49,304Ω to 47,124Ω. For an input range that accommodates down to 20° C.=0.5V the excitation current is given by: Excitation current=0.5V/128192=3.9 uA.


For this level of excitation, the change in A/D input at the worse case portion of the thermistor range (40° C.) is 49,304*3.9 uA-47,124*3.9 uA=8.5 mV. In certain embodiments, the effective thermistor temperature resolution includes 0.13/8.5=0.01° C.


In certain embodiments, the AFE for the temperature measurement interface may include the following characteristics and/or parameters. While specific values and/or ranges or values are provided below, within the scope of the present disclosure other suitable values and/or ranges of values are contemplated.














Item
Parameter
Value







1
Resistive temperature sensor
12 bits over the input operating



measurement resolution.
range.


2
Current source excitation.
+/−12%



Compatible with A/D input




requirement.



3
Channels
1 100 KΩ at 25° C. Thermistor




or 400 Ω RTD, and 1 Reference




resistor for a total of 2 inputs.




Individually multiplexed to the




same A/D converter and the same




current source.


4
Resistive temperature
+/−10 A/D Count.



measurement. Thermal




drift − offset. (specified




25° C. to 40° C.)



5
Resistive temperature
+/−0.5%



measurement. Thermal




drift − slope (specified




30° C. +/− 20° C.)



6
Internal band-gap
Less than or equal to about



temperature measurement
0.3° C.



resolution:



7
Internal band-gap
Less than or equal to about



temperature measurement
10° C.



offset error:



8
Internal band-gap
Less than or equal to about



temperature measurement
+/−1.5%



slope variation part to part:



6
ESD Protection
It is desirable to achieve




+/−2 KV HBM for each




pin on the ASIC.


7
RF interference
The specifications for




measurement accuracy must be




met when the reader is being




used to acquire data, or data




must be marked “bad”.









In certain embodiments, ASIC architecture is configured to withstand a 10 MeV e-beam with a dosage of about 25 kGy to about 60 kGy, such as, about 35 kGy, about 40 kGy, about 45 kGy, about 50 kGy, about 55 kGy, for example, for the on body electronics sterilization process to attain a desired predetermined sterility assurance level (SAL) (e.g., approximately 10−6 SAL). In certain embodiments, one or more predetermined annealing profiles may be provided for radiation recovery. Additional description related to sterilization can be found in U.S. Patent Publication No. 2009/0257911, the disclosure of which is incorporated by reference.


Certain embodiments may include an analyte sensor including a plurality of electrodes, including an in vivo portion of the analyte sensor configured for fluid contact with a bodily fluid under a skin layer, the analyte sensor configured to monitor an analyte level in the bodily fluid and to generate one or more signals associated with the monitored analyte level, and sensor electronics including a sensor interface section and a data processing section, the sensor interface section configured to electrically couple to the plurality of electrodes of the analyte sensor, and the data processing section configured to process one or more signals received from the analyte sensor, wherein the sensor interface section includes an electrical interface to couple to two electrodes of the plurality of electrodes, or three electrodes of the plurality of electrodes, and further wherein the data processing section includes an application specific integrated circuit with programmable logic to perform one or more operations of the data processing section including processing the one or more signals from the analyte sensor for filtering, calibration, storage, transmission, or one or more combinations thereof.


In certain embodiments, the application specific integrated circuit may include a state machine, and wherein the state machine is configured to implement the programmable logic.


In certain embodiments, the application specific integrated circuit may include a reduced instruction set computing (RISC) processor, wherein the RISC processor includes programming configured to implement the programmable logic.


In certain embodiments, the generated one or more signals from the sensor may include voltage signals.


In certain embodiments, the generated one or more signals from the sensor may include current signals.


In certain embodiments, two electrodes of the plurality of electrodes may include an anode and a cathode, wherein the anode comprises carbon or gold and sensing chemistry, and further, wherein the cathode includes platinum or platinized carbon.


In certain embodiments, the three electrodes of the plurality of electrodes may include a working electrode, a counter electrode and a reference electrode, wherein the working electrode comprises one or more of carbon, gold, silver, or platinum.


Certain embodiments may further include an antenna operatively coupled to the sensor electronics and configured to communicate data associated with the monitored analyte level.


In certain embodiments, the antenna may include a radio frequency antenna.


In certain embodiments, the application specific integrated circuit may include a radio frequency identification (RFID) communication component operatively coupled to the antenna.


In certain embodiments, the RFID communication component may be configured to transmit data corresponding to the monitored analyte level to a remote location.


In certain embodiments, the RFID communication component may be configured to transmit the data in response to a request received from the remote location.


Certain embodiments may include providing an analyte sensor including a plurality of electrodes, including an in vivo portion of the analyte sensor for fluid contact with a bodily fluid under a skin layer, the analyte sensor for monitoring an analyte level in the bodily fluid and for generating one or more signals associated with the monitored analyte level, and providing sensor electronics including a sensor interface section and a data processing section, wherein providing sensor electronics includes configuring the sensor interface section to electrically couple to the plurality of electrodes of the analyte sensor, and configuring the data processing section to process one or more signals received from the analyte sensor, wherein configuring the sensor interface section includes providing an electrical interface to couple to two electrodes of the plurality of electrodes, or three electrodes of the plurality of electrodes, and further wherein configuring the data processing section includes providing an application specific integrated circuit with programmable logic to perform one or more operations of the data processing section including processing the one or more signals from the analyte sensor for filtering, calibration, storage, transmission, or one or more combinations thereof.


In certain embodiments, providing the application specific integrated circuit may include providing a state machine to implement the programmable logic to process the one or more signals.


In certain embodiments, providing the application specific integrated circuit may include providing a reduced instruction set computing (RISC) processor configured to implement the programmable logic to process the one or more signals.


In certain embodiments, the one or more signals generated by the analyte sensor may include voltage signals.


In certain embodiments, the one or more signals generated by the analyte sensor may include current signals.


Certain embodiments may further include operatively coupling an antenna to the sensor electronics.


Certain embodiments may further include transmitting data corresponding to the monitored analyte level to a remote location via a radio frequency identification (RFID) communication component of the application specific integrated circuit operatively coupled to the antenna.


In certain embodiments, transmitting data corresponding to the monitored analyte level may include transmitting the data in response to a request received from the remote location.


Various other modifications and alterations in the structure and method of operation of the embodiments of the present disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the present disclosure. Although the present disclosure has been described in connection with certain embodiments, it should be understood that the present disclosure as claimed should not be unduly limited to such embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.

Claims
  • 1. An analyte monitoring device, comprising: an analyte sensor comprising a working electrode and a reference electrode, the analyte sensor configured to monitor an analyte level in a bodily fluid in a body; andsensor electronics including a sensor interface section and a data processing section, wherein the sensor interface section is operatively coupled to the working electrode and the reference electrode of the analyte sensor and configured to apply a voltage differential between the working electrode and the reference electrode,wherein the data processing section is configured to process one or more signals received from the analyte sensor,wherein the data processing section includes a circuit with programmable logic to filter, calibrate, store or transmit the one or more signals received from the analyte sensor, andwherein a first circuit path extends between the working electrode and the reference electrode and traverses only one amplifier, wherein the working electrode is coupled to an input of the only one amplifier and the reference electrode is coupled to an output of the only one amplifier.
  • 2. The device of claim 1, further including an antenna operatively coupled to the sensor electronics and configured to communicate data associated with the monitored analyte level.
  • 3. The device of claim 2, wherein the circuit includes a radio frequency identification (RFID) communication component operatively coupled to the antenna.
  • 4. The device of claim 1, wherein the data processing section comprises a multiplexer operatively coupled to the sensor interface section.
  • 5. The device of claim 1, wherein the input to the only one amplifier is a first input, and a second input of the only one amplifier is coupled to a reference voltage supply node.
  • 6. The device of claim 1, wherein the output of the only one amplifier feeds back to the input of the only one amplifier.
  • 7. The device of claim 6, wherein the only one amplifier is in an application specific integrated circuit (ASIC), and the feedback path is not in the ASIC.
  • 8. The device of claim 1, wherein the output of the only one amplifier feeds back to the input of the only one amplifier through a feedback resistor and a capacitor.
  • 9. The device of claim 1, wherein the analyte sensor does not comprise a counter electrode.
  • 10. The device of claim 1, wherein the first circuit path does not traverse a multiplexer.
  • 11. The device of claim 1, wherein the only one amplifier is configured to receive a sensor current at the input and convert that sensor current to a voltage on the output.
  • 12. A method of using an analyte monitoring device, wherein the analyte monitoring device comprises: an analyte sensor comprising a working electrode and a reference electrode, the analyte sensor configured to monitor an analyte level in a bodily fluid in a body; andsensor electronics including a sensor interface section and a data processing section, wherein the sensor interface section is operatively coupled to the working electrode and the reference electrode of the analyte sensor and configured to apply a voltage differential between the working electrode and the reference electrode,wherein a first circuit path extends between the working electrode and the reference electrode and traverses only one amplifier, wherein the working electrode is coupled to an input of the only one amplifier and the reference electrode is coupled to an output of the only one amplifier, the method comprising:communicating one or more signals from the analyte sensor to the data processing section; andprocessing, by a circuit of the data processing section, the one or more signals from the analyte sensor to filter, calibrate, store, or transmit the one or more signals.
  • 13. The method of claim 12, wherein an antenna is operably coupled to the sensor electronics.
  • 14. The method of claim 13, further comprising transmitting data corresponding to the monitored analyte level to a remote location via a radio frequency identification (RFID) communication component of the circuit operatively coupled to the antenna.
  • 15. The method of claim 12, wherein the data processing section comprises a multiplexer operatively coupled to the sensor interface section.
  • 16. The method of claim 12, wherein the input to the only one amplifier is a first input, and a second input of the only one amplifier is coupled to a reference voltage supply node.
  • 17. The method of claim 12, wherein the output of the only one amplifier feeds back to the input of the only one amplifier.
  • 18. The method of claim 17, wherein the only one amplifier is in an application specific integrated circuit (ASIC), and the feedback path is not in the ASIC.
  • 19. The method of claim 12, wherein the output of the only one amplifier feeds back to the input of the only one amplifier through a feedback resistor and a capacitor.
  • 20. The method of claim 12, wherein the analyte sensor does not comprise a counter electrode.
  • 21. The method of claim 12, wherein the first circuit path does not traverse a multiplexer.
  • 22. The method of claim 12, wherein the only one amplifier is configured to receive a sensor current at the input and convert that sensor current to a voltage on the output.
  • 23. An analyte monitoring device, comprising: an analyte sensor comprising a working electrode and a reference electrode, the analyte sensor configured to monitor an analyte level in a bodily fluid in a body; andsensor electronics including a sensor interface section and a data processing section, wherein the sensor interface section is operatively coupled to the working electrode and the reference electrode of the analyte sensor,wherein the data processing section is configured to process one or more signals received from the analyte sensor,wherein the data processing section includes a circuit with programmable logic to filter, calibrate, store or transmit the one or more signals received from the analyte sensor, andwherein a first circuit path extends between the working electrode and the reference electrode and traverses only one amplifier, wherein the working electrode is coupled to an input of the only one amplifier and the reference electrode is coupled to an output of the only one amplifier, and wherein the only one amplifier is configured to receive a sensor current at the input and convert that sensor current to a voltage on the output.
RELATED APPLICATION

The present application claims the benefit of U.S. provisional application No. 61/391,065 filed Oct. 7, 2010, entitled “Analyte Monitoring Devices and Methods”, the disclosure of which is incorporated herein by reference for all purposes.

US Referenced Citations (953)
Number Name Date Kind
3581062 Aston May 1971 A
3926760 Allen et al. Dec 1975 A
3949388 Fuller Apr 1976 A
4036749 Anderson Jul 1977 A
4055175 Clemens et al. Oct 1977 A
4129128 McFarlane Dec 1978 A
4245634 Albisser et al. Jan 1981 A
4327725 Cortese et al. May 1982 A
4344438 Schultz Aug 1982 A
4349728 Phillips et al. Sep 1982 A
4373527 Fischell Feb 1983 A
4392849 Petre et al. Jul 1983 A
4425920 Bourland et al. Jan 1984 A
4431004 Bessman et al. Feb 1984 A
4441968 Emmer et al. Apr 1984 A
4478976 Goertz et al. Oct 1984 A
4494950 Fischell Jan 1985 A
4509531 Ward Apr 1985 A
4527240 Kvitash Jul 1985 A
4538616 Rogoff Sep 1985 A
4619793 Lee Oct 1986 A
4671288 Gough Jun 1987 A
4703756 Gough et al. Nov 1987 A
4731726 Allen, III Mar 1988 A
4749985 Corsberg Jun 1988 A
4757022 Shults et al. Jul 1988 A
4777953 Ash et al. Oct 1988 A
4779618 Mund et al. Oct 1988 A
4847785 Stephens Jul 1989 A
4854322 Ash et al. Aug 1989 A
4871351 Feingold Oct 1989 A
4890620 Gough Jan 1990 A
4925268 Iyer et al. May 1990 A
4953552 DeMarzo Sep 1990 A
4986271 Wilkins Jan 1991 A
4995402 Smith et al. Feb 1991 A
5000180 Kuypers et al. Mar 1991 A
5002054 Ash et al. Mar 1991 A
5019974 Beckers May 1991 A
5050612 Matsumura Sep 1991 A
5051688 Murase et al. Sep 1991 A
5055171 Peck Oct 1991 A
5068536 Rosenthal Nov 1991 A
5082550 Rishpon et al. Jan 1992 A
5106365 Hernandez Apr 1992 A
5122925 Inpyn Jun 1992 A
5135004 Adams et al. Aug 1992 A
5165407 Wilson et al. Nov 1992 A
5202261 Musho et al. Apr 1993 A
5210778 Massart May 1993 A
5228449 Christ et al. Jul 1993 A
5231988 Wernicke et al. Aug 1993 A
5246867 Lakowicz et al. Sep 1993 A
5251126 Kahn et al. Oct 1993 A
5262035 Gregg et al. Nov 1993 A
5262305 Heller et al. Nov 1993 A
5264104 Gregg et al. Nov 1993 A
5264105 Gregg et al. Nov 1993 A
5279294 Anderson et al. Jan 1994 A
5285792 Sjoquist et al. Feb 1994 A
5293877 O'Hara et al. Mar 1994 A
5299571 Mastrototaro Apr 1994 A
5320725 Gregg et al. Jun 1994 A
5322063 Allen et al. Jun 1994 A
5327029 Ericson Jul 1994 A
5330634 Wong et al. Jul 1994 A
5340722 Wolfbeis et al. Aug 1994 A
5342789 Chick et al. Aug 1994 A
5356786 Heller et al. Oct 1994 A
5360404 Novacek et al. Nov 1994 A
5372427 Padovani et al. Dec 1994 A
5379238 Stark Jan 1995 A
5384547 Lynk et al. Jan 1995 A
5390671 Lord et al. Feb 1995 A
5391250 Cheney, II et al. Feb 1995 A
5408999 Singh et al. Apr 1995 A
5410326 Goldstein Apr 1995 A
5411647 Johnson et al. May 1995 A
5425868 Pedersen Jun 1995 A
5429602 Hauser Jul 1995 A
5431160 Wilkins Jul 1995 A
5431921 Thombre Jul 1995 A
5462645 Albery et al. Oct 1995 A
5497772 Schulman et al. Mar 1996 A
5505828 Wong et al. Apr 1996 A
5507288 Bocker et al. Apr 1996 A
5509410 Hill et al. Apr 1996 A
5514718 Lewis et al. May 1996 A
5531878 Vadgama et al. Jul 1996 A
5532686 Urbas et al. Jul 1996 A
5552997 Massart Sep 1996 A
5568400 Stark et al. Oct 1996 A
5568806 Cheney, II et al. Oct 1996 A
5569186 Lord et al. Oct 1996 A
5582184 Erickson et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5593852 Heller et al. Jan 1997 A
5609575 Larson et al. Mar 1997 A
5628310 Rao et al. May 1997 A
5634468 Platt et al. Jun 1997 A
5653239 Pompei et al. Aug 1997 A
5660163 Schulman et al. Aug 1997 A
5665222 Heller et al. Sep 1997 A
5707502 McCaffrey et al. Jan 1998 A
5711001 Bussan et al. Jan 1998 A
5711861 Ward Jan 1998 A
5724030 Urbas et al. Mar 1998 A
5733259 Valcke et al. Mar 1998 A
5749907 Mann May 1998 A
5772586 Heinonen et al. Jun 1998 A
5791344 Schulman et al. Aug 1998 A
5804047 Karube et al. Sep 1998 A
5833603 Kovacs et al. Nov 1998 A
5842189 Keeler et al. Nov 1998 A
5891049 Cyrus et al. Apr 1999 A
5899855 Brown May 1999 A
5925021 Castellano et al. Jul 1999 A
5935224 Svancarek et al. Aug 1999 A
5942979 Luppino Aug 1999 A
5951485 Cyrus et al. Sep 1999 A
5957854 Besson et al. Sep 1999 A
5964993 Blubaugh, Jr. et al. Oct 1999 A
5965380 Heller et al. Oct 1999 A
5971922 Arita et al. Oct 1999 A
5980708 Champagne et al. Nov 1999 A
5995860 Sun et al. Nov 1999 A
6001067 Shults et al. Dec 1999 A
6024699 Surwit et al. Feb 2000 A
6028413 Brockmann Feb 2000 A
6049727 Crothall Apr 2000 A
6052565 Ishikura et al. Apr 2000 A
6066243 Anderson et al. May 2000 A
6083710 Heller et al. Jul 2000 A
6088608 Schulman et al. Jul 2000 A
6091976 Pfeiffer et al. Jul 2000 A
6091987 Thompson Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6096364 Bok et al. Aug 2000 A
6103033 Say et al. Aug 2000 A
6117290 Say et al. Sep 2000 A
6119028 Schulman et al. Sep 2000 A
6120676 Heller et al. Sep 2000 A
6121009 Heller et al. Sep 2000 A
6121611 Lindsay et al. Sep 2000 A
6122351 Schlueter, Jr. et al. Sep 2000 A
6130623 MacLellan et al. Oct 2000 A
6134461 Say et al. Oct 2000 A
6143164 Heller et al. Nov 2000 A
6144871 Saito et al. Nov 2000 A
6162611 Heller et al. Dec 2000 A
6175752 Say et al. Jan 2001 B1
6200265 Walsh et al. Mar 2001 B1
6212416 Ward et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6233471 Berner et al. May 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6275717 Gross et al. Aug 2001 B1
6284478 Heller et al. Sep 2001 B1
6291200 LeJeune et al. Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6294997 Paratore et al. Sep 2001 B1
6295506 Heinonen et al. Sep 2001 B1
6299347 Pompei Oct 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309884 Cooper et al. Oct 2001 B1
6329161 Heller et al. Dec 2001 B1
6359270 Bridson Mar 2002 B1
6360888 McIvor et al. Mar 2002 B1
6366794 Moussy et al. Apr 2002 B1
6377828 Chaiken et al. Apr 2002 B1
6379301 Worthington et al. Apr 2002 B1
6387048 Schulman et al. May 2002 B1
6400974 Lesho Jun 2002 B1
6405066 Essenpreis et al. Jun 2002 B1
6413393 Van Antwerp et al. Jul 2002 B1
6416471 Kumar et al. Jul 2002 B1
6418346 Nelson et al. Jul 2002 B1
6424847 Mastrototaro et al. Jul 2002 B1
6427088 Bowman, IV et al. Jul 2002 B1
6440068 Brown et al. Aug 2002 B1
6471689 Joseph et al. Oct 2002 B1
6478736 Mault Nov 2002 B1
6484046 Say et al. Nov 2002 B1
6493069 Nagashimada et al. Dec 2002 B1
6496729 Thompson Dec 2002 B2
6497655 Linberg et al. Dec 2002 B1
6498043 Schulman et al. Dec 2002 B1
6514718 Heller et al. Feb 2003 B2
6520326 McIvor et al. Feb 2003 B2
6544212 Galley et al. Apr 2003 B2
6549796 Sohrab Apr 2003 B2
6551494 Heller et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6558321 Burd et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6560471 Heller et al. May 2003 B1
6561975 Pool et al. May 2003 B1
6561978 Conn et al. May 2003 B1
6562001 Lebel et al. May 2003 B2
6564105 Starkweather et al. May 2003 B2
6565509 Say et al. May 2003 B1
6571128 Lebel et al. May 2003 B2
6572545 Knobbe et al. Jun 2003 B2
6574510 Arx et al. Jun 2003 B2
6576101 Heller et al. Jun 2003 B1
6577899 Lebel et al. Jun 2003 B2
6579231 Phipps Jun 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6585644 Lebel et al. Jul 2003 B2
6591125 Buse et al. Jul 2003 B1
6595919 Berner et al. Jul 2003 B2
6605200 Mao et al. Aug 2003 B1
6605201 Mao et al. Aug 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6610012 Mault Aug 2003 B2
6633772 Ford et al. Oct 2003 B2
6635014 Starkweather et al. Oct 2003 B2
6635167 Batman et al. Oct 2003 B1
6641533 Causey, III et al. Nov 2003 B2
6648821 Lebel et al. Nov 2003 B2
6654625 Say et al. Nov 2003 B1
6656114 Poulsen et al. Dec 2003 B1
6658396 Tang et al. Dec 2003 B1
6659948 Lebel et al. Dec 2003 B2
6668196 Villegas et al. Dec 2003 B1
6675030 Ciuczak et al. Jan 2004 B2
6676816 Mao et al. Jan 2004 B2
6687546 Lebel et al. Feb 2004 B2
6689056 Kilcoyne et al. Feb 2004 B1
6694191 Starkweather et al. Feb 2004 B2
6695860 Ward et al. Feb 2004 B1
6698269 Baber et al. Mar 2004 B2
6702857 Brauker et al. Mar 2004 B2
6731976 Penn et al. May 2004 B2
6733446 Lebel et al. May 2004 B2
6735183 O'Toole et al. May 2004 B2
6740075 Lebel et al. May 2004 B2
6740518 Duong et al. May 2004 B1
6741877 Shults et al. May 2004 B1
6746582 Heller et al. Jun 2004 B2
6758810 Lebel et al. Jul 2004 B2
6770030 Schaupp et al. Aug 2004 B1
6789195 Prihoda et al. Sep 2004 B1
6790178 Mault et al. Sep 2004 B1
6804558 Haller et al. Oct 2004 B2
6809653 Mann et al. Oct 2004 B1
6810290 Lebel et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6811534 Bowman, IV et al. Nov 2004 B2
6813519 Lebel et al. Nov 2004 B2
6850790 Berner et al. Feb 2005 B2
6862465 Shults et al. Mar 2005 B2
6865407 Kimball et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6878112 Linberg et al. Apr 2005 B2
6881551 Heller et al. Apr 2005 B2
6882940 Potts et al. Apr 2005 B2
6892085 Mclvor et al. May 2005 B2
6895263 Shin et al. May 2005 B2
6895265 Silver May 2005 B2
6923764 Aceti et al. Aug 2005 B2
6931327 Goode, Jr. et al. Aug 2005 B2
6932894 Mao et al. Aug 2005 B2
6936006 Sabra Aug 2005 B2
6940403 Kail, IV Sep 2005 B2
6941163 Ford et al. Sep 2005 B2
6950708 Bowman, IV et al. Sep 2005 B2
6958705 Lebel et al. Oct 2005 B2
6968294 Gutta et al. Nov 2005 B2
6971274 Olin Dec 2005 B2
6974437 Lebel et al. Dec 2005 B2
6983176 Gardner et al. Jan 2006 B2
6990366 Say et al. Jan 2006 B2
6997907 Safabash et al. Feb 2006 B2
6998247 Monfre et al. Feb 2006 B2
7003336 Holker et al. Feb 2006 B2
7003340 Say et al. Feb 2006 B2
7003341 Say et al. Feb 2006 B2
7009511 Mazar et al. Mar 2006 B2
7020508 Stivoric et al. Mar 2006 B2
7022072 Fox et al. Apr 2006 B2
7024236 Ford et al. Apr 2006 B2
7024245 Lebel et al. Apr 2006 B2
7025425 Kovatchev et al. Apr 2006 B2
7027848 Robinson et al. Apr 2006 B2
7027931 Jones et al. Apr 2006 B1
7029444 Shin et al. Apr 2006 B2
7041068 Freeman et al. May 2006 B2
7043305 KenKnight et al. May 2006 B2
7052483 Wojcik May 2006 B2
7056302 Douglas Jun 2006 B2
7058453 Nelson et al. Jun 2006 B2
7060031 Webb et al. Jun 2006 B2
7074307 Simpson et al. Jul 2006 B2
7081195 Simpson et al. Jul 2006 B2
7082334 Boute et al. Jul 2006 B2
7092891 Maus et al. Aug 2006 B2
7098803 Mann et al. Aug 2006 B2
7108778 Simpson et al. Sep 2006 B2
7110803 Shults et al. Sep 2006 B2
7113821 Sun et al. Sep 2006 B1
7118667 Lee Oct 2006 B2
7125382 Zhou et al. Oct 2006 B2
7134999 Brauker et al. Nov 2006 B2
7136689 Shults et al. Nov 2006 B2
7153265 Vachon Dec 2006 B2
7155290 Von Arx et al. Dec 2006 B2
7171274 Starkweather et al. Jan 2007 B2
7190988 Say et al. Mar 2007 B2
7192450 Brauker et al. Mar 2007 B2
7198606 Boecker et al. Apr 2007 B2
7203549 Schommer et al. Apr 2007 B2
7207974 Safabash et al. Apr 2007 B2
7225535 Feldman et al. Jun 2007 B2
7226442 Sheppard et al. Jun 2007 B2
7226978 Tapsak et al. Jun 2007 B2
7228182 Healy et al. Jun 2007 B2
7237712 DeRocco et al. Jul 2007 B2
7258673 Racchini et al. Aug 2007 B2
7267665 Steil et al. Sep 2007 B2
7276029 Goode, Jr. et al. Oct 2007 B2
7278983 Ireland et al. Oct 2007 B2
7286894 Grant et al. Oct 2007 B1
7295867 Berner et al. Nov 2007 B2
7299082 Feldman et al. Nov 2007 B2
7310544 Brister et al. Dec 2007 B2
7317938 Lorenz et al. Jan 2008 B2
7318816 Bobroff et al. Jan 2008 B2
7324850 Persen et al. Jan 2008 B2
7335294 Heller et al. Feb 2008 B2
7354420 Steil et al. Apr 2008 B2
7364592 Carr-Brendel et al. Apr 2008 B2
7366556 Brister et al. Apr 2008 B2
7347819 Lebel et al. May 2008 B2
7379765 Petisce et al. May 2008 B2
7384397 Zhang et al. Jun 2008 B2
7387010 Sunshine et al. Jun 2008 B2
7399277 Saidara et al. Jul 2008 B2
7402153 Steil et al. Jul 2008 B2
7404796 Ginsberg Jul 2008 B2
7419573 Gundel Sep 2008 B2
7424318 Brister et al. Sep 2008 B2
7460898 Brister et al. Dec 2008 B2
7467003 Brister et al. Dec 2008 B2
7471972 Rhodes et al. Dec 2008 B2
7474992 Ariyur Jan 2009 B2
7492254 Bandy et al. Feb 2009 B2
7494465 Brister et al. Feb 2009 B2
7497827 Brister et al. Mar 2009 B2
7519408 Rasdal et al. Apr 2009 B2
7547281 Hayes et al. Jun 2009 B2
7565197 Haubrich et al. Jul 2009 B2
7569030 Lebel et al. Aug 2009 B2
7574266 Pudding et al. Aug 2009 B2
7583990 Goode, Jr. et al. Sep 2009 B2
7591801 Brauker et al. Sep 2009 B2
7599726 Goode, Jr. et al. Oct 2009 B2
7602310 Mann et al. Oct 2009 B2
7604178 Stewart Oct 2009 B2
7613491 Boock et al. Nov 2009 B2
7615007 Shults et al. Nov 2009 B2
7618369 Hayter et al. Nov 2009 B2
7630748 Budiman Dec 2009 B2
7632228 Brauker et al. Dec 2009 B2
7637868 Saint et al. Dec 2009 B2
7640048 Dobbies et al. Dec 2009 B2
7651596 Petisce et al. Jan 2010 B2
7651845 Doyle, III et al. Jan 2010 B2
7653425 Hayter et al. Jan 2010 B2
7654956 Brister et al. Feb 2010 B2
7657297 Simpson et al. Feb 2010 B2
7659823 Killian et al. Feb 2010 B1
7668596 Arx et al. Feb 2010 B2
7699775 Desai et al. Apr 2010 B2
7699964 Feldman et al. Apr 2010 B2
7711402 Shults et al. May 2010 B2
7713574 Brister et al. May 2010 B2
7715893 Kamath et al. May 2010 B2
7741734 Joannopoulos et al. Jun 2010 B2
7766829 Sloan et al. Aug 2010 B2
7768386 Hayter et al. Aug 2010 B2
7768387 Fennell et al. Aug 2010 B2
7771352 Shults et al. Aug 2010 B2
7774145 Brauker et al. Aug 2010 B2
7778680 Goode et al. Aug 2010 B2
7779332 Karr et al. Aug 2010 B2
7782192 Jeckelmann et al. Aug 2010 B2
7783333 Brister et al. Aug 2010 B2
7791467 Mazar et al. Sep 2010 B2
7792562 Shults et al. Sep 2010 B2
7813809 Strother et al. Oct 2010 B2
7826382 Sicurello et al. Nov 2010 B2
7826981 Goode, Jr. et al. Nov 2010 B2
7831310 Lebel et al. Nov 2010 B2
7860574 Arx et al. Dec 2010 B2
7882611 Shah et al. Feb 2011 B2
7889069 Fifolt et al. Feb 2011 B2
7899511 Shults et al. Mar 2011 B2
7899545 John Mar 2011 B2
7905833 Brister et al. Mar 2011 B2
7912674 Killoren Clark et al. Mar 2011 B2
7914450 Goode, Jr. et al. Mar 2011 B2
7916013 Stevenson Mar 2011 B2
7920906 Goode et al. Apr 2011 B2
7928850 Hayter et al. Apr 2011 B2
7955258 Goscha et al. Jun 2011 B2
7970448 Shults et al. Jun 2011 B2
7974672 Shults et al. Jul 2011 B2
7976466 Ward et al. Jul 2011 B2
7978063 Baldus et al. Jul 2011 B2
7999674 Kamen Aug 2011 B2
8010174 Goode et al. Aug 2011 B2
8072310 Everhart Dec 2011 B1
8090445 Ginggen Jan 2012 B2
8093991 Stevenson et al. Jan 2012 B2
8094009 Allen et al. Jan 2012 B2
8098159 Batra et al. Jan 2012 B2
8098160 Howarth et al. Jan 2012 B2
8098161 Lavedas Jan 2012 B2
8098201 Choi et al. Jan 2012 B2
8098208 Ficker et al. Jan 2012 B2
8102021 Degani Jan 2012 B2
8102154 Bishop et al. Jan 2012 B2
8102263 Yeo et al. Jan 2012 B2
8102789 Rosar et al. Jan 2012 B2
8103241 Young et al. Jan 2012 B2
8103325 Swedlow et al. Jan 2012 B2
8111042 Bennett Feb 2012 B2
8115488 McDowell Feb 2012 B2
8116681 Baarman Feb 2012 B2
8116683 Baarman Feb 2012 B2
8117481 Anselmi et al. Feb 2012 B2
8120493 Burr Feb 2012 B2
8124452 Sheats Feb 2012 B2
8130093 Mazar et al. Mar 2012 B2
8131351 Kalgren et al. Mar 2012 B2
8131365 Zhang et al. Mar 2012 B2
8131565 Dicks et al. Mar 2012 B2
8132037 Fehr et al. Mar 2012 B2
8135352 Langsweirdt et al. Mar 2012 B2
8136735 Arai et al. Mar 2012 B2
8138925 Downie et al. Mar 2012 B2
8140160 Pless et al. Mar 2012 B2
8140168 Olson et al. Mar 2012 B2
8140299 Siess Mar 2012 B2
8150321 Winter et al. Apr 2012 B2
8150516 Levine et al. Apr 2012 B2
8179266 Hermle May 2012 B2
8192394 Estes et al. Jun 2012 B2
8216138 McGarraugh et al. Jul 2012 B1
8282549 Brauker et al. Oct 2012 B2
20010037366 Webb et al. Nov 2001 A1
20020019022 Dunn et al. Feb 2002 A1
20020019612 Watanabe et al. Feb 2002 A1
20020042090 Heller et al. Apr 2002 A1
20020054320 Ogino May 2002 A1
20020068860 Clark Jun 2002 A1
20020072784 Sheppard et al. Jun 2002 A1
20020103499 Perez et al. Aug 2002 A1
20020106709 Potts et al. Aug 2002 A1
20020128594 Das et al. Sep 2002 A1
20020161288 Shin et al. Oct 2002 A1
20020169439 Flaherty et al. Nov 2002 A1
20020169635 Shillingburg Nov 2002 A1
20030004403 Drinan et al. Jan 2003 A1
20030010089 Holmes Jan 2003 A1
20030023317 Brauker et al. Jan 2003 A1
20030028089 Galley et al. Feb 2003 A1
20030032874 Rhodes et al. Feb 2003 A1
20030042137 Mao et al. Mar 2003 A1
20030055380 Flaherty et al. Mar 2003 A1
20030060692 Ruchti et al. Mar 2003 A1
20030065308 Lebel et al. Apr 2003 A1
20030076082 Morgan Apr 2003 A1
20030100040 Bonnecaze et al. May 2003 A1
20030100821 Heller et al. May 2003 A1
20030114897 Von Arx et al. Jun 2003 A1
20030125612 Fox et al. Jul 2003 A1
20030130616 Steil et al. Jul 2003 A1
20030134347 Heller et al. Jul 2003 A1
20030147515 Kai et al. Aug 2003 A1
20030167035 Flaherty et al. Sep 2003 A1
20030168338 Gao et al. Sep 2003 A1
20030176933 Lebel et al. Sep 2003 A1
20030187338 Say et al. Oct 2003 A1
20030191377 Robinson et al. Oct 2003 A1
20030199790 Boecker et al. Oct 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030212317 Kovatchev et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030216630 Jersey-Willuhn et al. Nov 2003 A1
20030217966 Tapsak et al. Nov 2003 A1
20030225361 Sabra Dec 2003 A1
20040010186 Kimball et al. Jan 2004 A1
20040010207 Flaherty et al. Jan 2004 A1
20040011671 Shults et al. Jan 2004 A1
20040015131 Flaherty et al. Jan 2004 A1
20040024553 Monfre et al. Feb 2004 A1
20040039298 Abreu Feb 2004 A1
20040040840 Mao et al. Mar 2004 A1
20040045879 Shults et al. Mar 2004 A1
20040041749 Dixon Apr 2004 A1
20040063435 Sakamoto et al. Apr 2004 A1
20040064068 DeNuzzio et al. Apr 2004 A1
20040064088 Gorman et al. Apr 2004 A1
20040064096 Flaherty et al. Apr 2004 A1
20040099529 Mao et al. May 2004 A1
20040106858 Say et al. Jun 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040133164 Funderburk et al. Jul 2004 A1
20040138588 Saikley et al. Jul 2004 A1
20040146909 Duong et al. Jul 2004 A1
20040152622 Keith et al. Aug 2004 A1
20040153032 Garribotto et al. Aug 2004 A1
20040158167 Smith Aug 2004 A1
20040167464 Ireland et al. Aug 2004 A1
20040167801 Say et al. Aug 2004 A1
20040171921 Say et al. Sep 2004 A1
20040176672 Silver et al. Sep 2004 A1
20040186362 Brauker et al. Sep 2004 A1
20040186365 Jin et al. Sep 2004 A1
20040193025 Steil et al. Sep 2004 A1
20040193090 Lebel et al. Sep 2004 A1
20040197846 Hockersmith et al. Oct 2004 A1
20040199059 Brauker et al. Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204868 Maynard et al. Oct 2004 A1
20040219664 Heller et al. Nov 2004 A1
20040225338 Lebel et al. Nov 2004 A1
20040236200 Say et al. Nov 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040260478 Schwamm Dec 2004 A1
20040267300 Mace Dec 2004 A1
20050001024 Kusaka et al. Jan 2005 A1
20050004439 Shin et al. Jan 2005 A1
20050004494 Perez et al. Jan 2005 A1
20050010269 Lebel et al. Jan 2005 A1
20050027177 Shin et al. Feb 2005 A1
20050027180 Goode et al. Feb 2005 A1
20050027181 Goode et al. Feb 2005 A1
20050027462 Goode et al. Feb 2005 A1
20050027463 Goode et al. Feb 2005 A1
20050031689 Shults et al. Feb 2005 A1
20050038332 Saidara et al. Feb 2005 A1
20050043598 Goode, Jr. et al. Feb 2005 A1
20050049179 Davidson et al. Mar 2005 A1
20050070777 Cho et al. Mar 2005 A1
20050090607 Tapsak et al. Apr 2005 A1
20050096511 Fox et al. May 2005 A1
20050096512 Fox et al. May 2005 A1
20050112169 Brauker et al. May 2005 A1
20050113653 Fox et al. May 2005 A1
20050113886 Fischell et al. May 2005 A1
20050114068 Chey et al. May 2005 A1
20050115832 Simpson et al. Jun 2005 A1
20050116683 Cheng et al. Jun 2005 A1
20050121322 Say et al. Jun 2005 A1
20050131346 Douglas Jun 2005 A1
20050137530 Campbell et al. Jun 2005 A1
20050143635 Kamath et al. Jun 2005 A1
20050176136 Burd et al. Aug 2005 A1
20050177398 Watanabe et al. Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050187720 Goode, Jr. et al. Aug 2005 A1
20050192494 Ginsberg Sep 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050195930 Spital et al. Sep 2005 A1
20050199494 Say et al. Sep 2005 A1
20050203360 Brauker et al. Sep 2005 A1
20050204134 Von Arx et al. Sep 2005 A1
20050239154 Feldman et al. Oct 2005 A1
20050241957 Mao et al. Nov 2005 A1
20050244811 Soundarrajan Nov 2005 A1
20050245795 Goode, Jr. et al. Nov 2005 A1
20050245799 Brauker et al. Nov 2005 A1
20050245839 Stivoric et al. Nov 2005 A1
20050245904 Estes et al. Nov 2005 A1
20050251033 Scarantino et al. Nov 2005 A1
20050272985 Kotulla et al. Dec 2005 A1
20050277912 John Dec 2005 A1
20050287620 Heller et al. Dec 2005 A1
20060001538 Kraft et al. Jan 2006 A1
20060001551 Kraft et al. Jan 2006 A1
20060004270 Bedard et al. Jan 2006 A1
20060015020 Neale et al. Jan 2006 A1
20060015024 Brister et al. Jan 2006 A1
20060016700 Brister et al. Jan 2006 A1
20060017923 Ruchti et al. Jan 2006 A1
20060019327 Brister et al. Jan 2006 A1
20060020186 Brister et al. Jan 2006 A1
20060020187 Brister et al. Jan 2006 A1
20060020188 Kamath et al. Jan 2006 A1
20060020189 Brister et al. Jan 2006 A1
20060020190 Kamath et al. Jan 2006 A1
20060020191 Brister et al. Jan 2006 A1
20060020192 Brister et al. Jan 2006 A1
20060025663 Talbot et al. Feb 2006 A1
20060029177 Cranford, Jr. et al. Feb 2006 A1
20060031094 Cohen et al. Feb 2006 A1
20060036139 Brister et al. Feb 2006 A1
20060036140 Brister et al. Feb 2006 A1
20060036141 Kamath et al. Feb 2006 A1
20060036142 Brister et al. Feb 2006 A1
20060036143 Brister et al. Feb 2006 A1
20060036144 Brister et al. Feb 2006 A1
20060036145 Brister et al. Feb 2006 A1
20060142651 Brister et al. Jun 2006 A1
20060154642 Scannell Jul 2006 A1
20060155180 Brister et al. Jul 2006 A1
20060156796 Burke et al. Jul 2006 A1
20060166629 Reggiardo Jul 2006 A1
20060173260 Gaoni et al. Aug 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060173444 Choy et al. Aug 2006 A1
20060183985 Brister et al. Aug 2006 A1
20060189863 Peyser et al. Aug 2006 A1
20060202805 Schulman et al. Sep 2006 A1
20060211072 Ryan et al. Sep 2006 A1
20060222566 Brauker et al. Oct 2006 A1
20060224109 Steil et al. Oct 2006 A1
20060224141 Rush et al. Oct 2006 A1
20060229512 Petisce et al. Oct 2006 A1
20060247508 Fennell Nov 2006 A1
20060247710 Goetz et al. Nov 2006 A1
20060253296 Liisberg et al. Nov 2006 A1
20060258929 Goode et al. Nov 2006 A1
20060272652 Stocker et al. Dec 2006 A1
20060281985 Ward et al. Dec 2006 A1
20060287691 Drew Dec 2006 A1
20060290496 Peeters et al. Dec 2006 A1
20060293607 Alt et al. Dec 2006 A1
20070000163 Kamath et al. Jan 2007 A1
20070010950 Abensour et al. Jan 2007 A1
20070000273 Stafford Feb 2007 A1
20070032706 Kamath et al. Feb 2007 A1
20070033074 Nitzan et al. Feb 2007 A1
20070055799 Koehler et al. Mar 2007 A1
20070060803 Liljeryd et al. Mar 2007 A1
20070060814 Stafford Mar 2007 A1
20070060869 Tolle et al. Mar 2007 A1
20070060979 Strother et al. Mar 2007 A1
20070066873 Kamath et al. Mar 2007 A1
20070066956 Finkel Mar 2007 A1
20070071681 Gadkar et al. Mar 2007 A1
20070073129 Shah et al. Mar 2007 A1
20070078320 Stafford Apr 2007 A1
20070078321 Mazza et al. Apr 2007 A1
20070078322 Stafford Apr 2007 A1
20070078323 Reggiardo et al. Apr 2007 A1
20070078818 Zvitz et al. Apr 2007 A1
20070093786 Goldsmith et al. Apr 2007 A1
20070094216 Mathias et al. Apr 2007 A1
20070100222 Mastrototaro et al. May 2007 A1
20070106135 Sloan et al. May 2007 A1
20070118405 Campbell et al. May 2007 A1
20070124002 Estes et al. May 2007 A1
20070149875 Quyang et al. Jun 2007 A1
20070151869 Heller et al. Jul 2007 A1
20070156033 Causey, III et al. Jul 2007 A1
20070163880 Woo et al. Jul 2007 A1
20070168224 Letzt et al. Jul 2007 A1
20070173706 Neinast et al. Jul 2007 A1
20070173761 Kanderian et al. Jul 2007 A1
20070179349 Hoyme et al. Aug 2007 A1
20070179352 Randlov et al. Aug 2007 A1
20070191701 Feldman et al. Aug 2007 A1
20070203407 Hoss et al. Aug 2007 A1
20070203966 Brauker et al. Aug 2007 A1
20070208246 Brauker et al. Sep 2007 A1
20070213657 Jennewine et al. Sep 2007 A1
20070002443 Talbot et al. Oct 2007 A1
20070228071 Kamen et al. Oct 2007 A1
20070232880 Siddiqui et al. Oct 2007 A1
20070235331 Simpson et al. Oct 2007 A1
20070249922 Peyser et al. Oct 2007 A1
20070253021 Mehta et al. Nov 2007 A1
20070255348 Holtzclaw Nov 2007 A1
20070255531 Drew Nov 2007 A1
20070258395 Jollota et al. Nov 2007 A1
20070270672 Hayter Nov 2007 A1
20070271285 Eichom et al. Nov 2007 A1
20070282299 Hellwig Dec 2007 A1
20070285238 Batra Dec 2007 A1
20070299617 Willis Dec 2007 A1
20080009692 Stafford Jan 2008 A1
20080017522 Heller et al. Jan 2008 A1
20080018433 Pitt-Pladdy Jan 2008 A1
20080021436 Wolpert et al. Jan 2008 A1
20080021666 Goode, Jr. et al. Jan 2008 A1
20080029391 Mao et al. Feb 2008 A1
20080030369 Mann et al. Feb 2008 A1
20080033254 Kamath et al. Feb 2008 A1
20080039702 Hayter et al. Feb 2008 A1
20080045824 Tapsak et al. Feb 2008 A1
20080058625 McGarraugh et al. Mar 2008 A1
20080058773 John Mar 2008 A1
20080060955 Goodnow Mar 2008 A1
20080061961 John Mar 2008 A1
20080064937 McGarraugh et al. Mar 2008 A1
20080064943 Talbot et al. Mar 2008 A1
20080071156 Brister et al. Mar 2008 A1
20080071157 McGarraugh et al. Mar 2008 A1
20080071158 McGarraugh et al. Mar 2008 A1
20080071328 Haubrich et al. Mar 2008 A1
20080081977 Hayter et al. Apr 2008 A1
20080083617 Simpson et al. Apr 2008 A1
20080086042 Brister et al. Apr 2008 A1
20080086044 Brister et al. Apr 2008 A1
20080086273 Shults et al. Apr 2008 A1
20080097289 Steil et al. Apr 2008 A1
20080108942 Brister et al. May 2008 A1
20080119705 Patel et al. May 2008 A1
20080139910 Mastrototaro et al. Jun 2008 A1
20080154513 Kovatchev et al. Jun 2008 A1
20080161666 Feldman et al. Jul 2008 A1
20080161707 Farringdon Jul 2008 A1
20080167543 Say et al. Jul 2008 A1
20080167572 Stivoric et al. Jul 2008 A1
20080172205 Breton et al. Jul 2008 A1
20080182537 Manku et al. Jul 2008 A1
20080183060 Steil et al. Jul 2008 A1
20080183061 Goode et al. Jul 2008 A1
20080183399 Goode et al. Jul 2008 A1
20080188731 Brister et al. Aug 2008 A1
20080188796 Steil et al. Aug 2008 A1
20080189051 Goode et al. Aug 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080194935 Brister et al. Aug 2008 A1
20080194936 Goode et al. Aug 2008 A1
20080194937 Goode et al. Aug 2008 A1
20080194938 Brister et al. Aug 2008 A1
20080195232 Carr-Brendel et al. Aug 2008 A1
20080195967 Goode et al. Aug 2008 A1
20080197024 Simpson et al. Aug 2008 A1
20080200788 Brister et al. Aug 2008 A1
20080200789 Brister et al. Aug 2008 A1
20080200791 Simpson et al. Aug 2008 A1
20080208025 Shults et al. Aug 2008 A1
20080208026 Noujaim et al. Aug 2008 A1
20080208113 Damiano et al. Aug 2008 A1
20080214915 Brister et al. Sep 2008 A1
20080214918 Brister et al. Sep 2008 A1
20080228051 Shults et al. Sep 2008 A1
20080228054 Shults et al. Sep 2008 A1
20080228055 Sher Sep 2008 A1
20080234663 Yodfat et al. Sep 2008 A1
20080235469 Drew Sep 2008 A1
20080242961 Brister et al. Oct 2008 A1
20080255434 Hayter et al. Oct 2008 A1
20080255437 Hayter Oct 2008 A1
20080255438 Saidara et al. Oct 2008 A1
20080255808 Hayter Oct 2008 A1
20080256048 Hayter Oct 2008 A1
20080262304 Nisani Oct 2008 A1
20080262469 Brister et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080275313 Brister et al. Nov 2008 A1
20080281179 Fennell Nov 2008 A1
20080287761 Hayter Nov 2008 A1
20080287762 Hayter Nov 2008 A1
20080287763 Hayter Nov 2008 A1
20080287764 Rasdal et al. Nov 2008 A1
20080287765 Rasdal et al. Nov 2008 A1
20080287766 Rasdal et al. Nov 2008 A1
20080288180 Hayter Nov 2008 A1
20080288204 Hayter et al. Nov 2008 A1
20080296155 Shults et al. Dec 2008 A1
20080306368 Goode et al. Dec 2008 A1
20080306434 Dobbies et al. Dec 2008 A1
20080306435 Kamath et al. Dec 2008 A1
20080306444 Brister et al. Dec 2008 A1
20080312518 Jina et al. Dec 2008 A1
20080312841 Hayter Dec 2008 A1
20080312842 Hayter Dec 2008 A1
20080312844 Hayter et al. Dec 2008 A1
20080312845 Hayter et al. Dec 2008 A1
20080314395 Kovatchev et al. Dec 2008 A1
20080319279 Ramsay et al. Dec 2008 A1
20090005665 Hayter et al. Jan 2009 A1
20090005666 Shin et al. Jan 2009 A1
20090006034 Hayter et al. Jan 2009 A1
20090006133 Weinert et al. Jan 2009 A1
20090012379 Goode et al. Jan 2009 A1
20090018424 Kamath et al. Jan 2009 A1
20090018425 Quyang et al. Jan 2009 A1
20090027040 Kermani Jan 2009 A1
20090030294 Petisce et al. Jan 2009 A1
20090033482 Hayter et al. Feb 2009 A1
20090036747 Hayter et al. Feb 2009 A1
20090036758 Brauker et al. Feb 2009 A1
20090036760 Hayter Feb 2009 A1
20090036763 Brauker et al. Feb 2009 A1
20090043181 Brauker et al. Feb 2009 A1
20090043182 Brauker et al. Feb 2009 A1
20090043525 Brauker et al. Feb 2009 A1
20090043541 Brauker et al. Feb 2009 A1
20090043542 Brauker et al. Feb 2009 A1
20090045055 Rhodes et al. Feb 2009 A1
20090048503 Dalal et al. Feb 2009 A1
20090054748 Feldman et al. Feb 2009 A1
20090055149 Hayter et al. Feb 2009 A1
20090062633 Brauker et al. Mar 2009 A1
20090062635 Brauker et al. Mar 2009 A1
20090062767 VanAntwerp et al. Mar 2009 A1
20090063402 Hayter Mar 2009 A1
20090076356 Simpson et al. Mar 2009 A1
20090076360 Brister et al. Mar 2009 A1
20090076361 Kamath et al. Mar 2009 A1
20090082693 Stafford Mar 2009 A1
20090085768 Patel et al. Apr 2009 A1
20090085873 Betts et al. Apr 2009 A1
20090088614 Taub et al. Apr 2009 A1
20090099436 Brister et al. Apr 2009 A1
20090105554 Stahmann et al. Apr 2009 A1
20090105560 Solomon Apr 2009 A1
20090105636 Hayter et al. Apr 2009 A1
20090112478 Mueller, Jr. et al. Apr 2009 A1
20090118604 Phan May 2009 A1
20090124877 Goode et al. May 2009 A1
20090124878 Goode et al. May 2009 A1
20090124879 Brister et al. May 2009 A1
20090124964 Leach et al. May 2009 A1
20090131768 Simpson et al. May 2009 A1
20090131769 Leach et al. May 2009 A1
20090131776 Simpson et al. May 2009 A1
20090131777 Simpson et al. May 2009 A1
20090137886 Shariati et al. May 2009 A1
20090137887 Shariati et al. May 2009 A1
20090143659 Li et al. Jun 2009 A1
20090143660 Brister et al. Jun 2009 A1
20090150186 Cohen et al. Jun 2009 A1
20090156919 Brister et al. Jun 2009 A1
20090156924 Shariati et al. Jun 2009 A1
20090163790 Brister et al. Jun 2009 A1
20090163791 Brister et al. Jun 2009 A1
20090164190 Hayter Jun 2009 A1
20090164239 Hayter et al. Jun 2009 A1
20090164251 Hayter Jun 2009 A1
20090001923 Shariati et al. Jul 2009 A1
20090178459 Li et al. Jul 2009 A1
20090182217 Li et al. Jul 2009 A1
20090189738 Hermle Jul 2009 A1
20090192366 Mensinger et al. Jul 2009 A1
20090192722 Shariati et al. Jul 2009 A1
20090192724 Brauker et al. Jul 2009 A1
20090192745 Kamath et al. Jul 2009 A1
20090192751 Kamath et al. Jul 2009 A1
20090198118 Hayter et al. Aug 2009 A1
20090203981 Brauker et al. Aug 2009 A1
20090204341 Brauker et al. Aug 2009 A1
20090209904 Peeters Aug 2009 A1
20090216100 Ebner et al. Aug 2009 A1
20090216103 Brister et al. Aug 2009 A1
20090227855 Hill et al. Sep 2009 A1
20090234200 Husheer Sep 2009 A1
20090240120 Mensinger et al. Sep 2009 A1
20090240128 Mensinger et al. Sep 2009 A1
20090240193 Mensinger et al. Sep 2009 A1
20090240440 Shurabura et al. Sep 2009 A1
20090242399 Kamath et al. Oct 2009 A1
20090242425 Kamath et al. Oct 2009 A1
20090247855 Boock et al. Oct 2009 A1
20090247856 Boock et al. Oct 2009 A1
20090247857 Harper et al. Oct 2009 A1
20090247931 Damgaard-Sorensen Oct 2009 A1
20090253973 Bashan et al. Oct 2009 A1
20090259118 Feldman et al. Oct 2009 A1
20090267765 Greene et al. Oct 2009 A1
20090287073 Boock et al. Nov 2009 A1
20090287074 Shults et al. Nov 2009 A1
20090289796 Blumberg Nov 2009 A1
20090292188 Hoss et al. Nov 2009 A1
20090296742 Sicurello et al. Dec 2009 A1
20090298182 Schulat et al. Dec 2009 A1
20090299155 Yang et al. Dec 2009 A1
20090299156 Simpson et al. Dec 2009 A1
20090299162 Brauker et al. Dec 2009 A1
20090299276 Brauker et al. Dec 2009 A1
20090318792 Fennell et al. Dec 2009 A1
20100010324 Brauker et al. Jan 2010 A1
20100010331 Brauker et al. Jan 2010 A1
20100010332 Brauker et al. Jan 2010 A1
20100016687 Brauker et al. Jan 2010 A1
20100016698 Rasdal et al. Jan 2010 A1
20100022855 Brauker et al. Jan 2010 A1
20100030038 Brauker et al. Feb 2010 A1
20100030053 Goode, Jr. et al. Feb 2010 A1
20100030484 Brauker et al. Feb 2010 A1
20100030485 Brauker et al. Feb 2010 A1
20100036215 Goode, Jr. et al. Feb 2010 A1
20100036216 Goode, Jr. et al. Feb 2010 A1
20100036222 Goode, Jr. et al. Feb 2010 A1
20100036223 Goode, Jr. et al. Feb 2010 A1
20100036225 Goode, Jr. et al. Feb 2010 A1
20100041971 Goode, Jr. et al. Feb 2010 A1
20100045465 Brauker et al. Feb 2010 A1
20100049024 Saint et al. Feb 2010 A1
20100056992 Hayter et al. Mar 2010 A1
20100057040 Hayter Mar 2010 A1
20100057041 Hayter Mar 2010 A1
20100057042 Hayter Mar 2010 A1
20100057044 Hayter Mar 2010 A1
20100057057 Hayter et al. Mar 2010 A1
20100063373 Kamath et al. Mar 2010 A1
20100076283 Simpson et al. Mar 2010 A1
20100081906 Hayter et al. Apr 2010 A1
20100081908 Dobbies et al. Apr 2010 A1
20100081909 Budiman et al. Apr 2010 A1
20100081910 Brister et al. Apr 2010 A1
20100087724 Brauker et al. Apr 2010 A1
20100096259 Zhang et al. Apr 2010 A1
20100099970 Shults et al. Apr 2010 A1
20100099971 Shults et al. Apr 2010 A1
20100105999 Dixon et al. Apr 2010 A1
20100119693 Tapsak et al. May 2010 A1
20100121169 Petisce et al. May 2010 A1
20100152554 Steine et al. Jun 2010 A1
20100160759 Celentano et al. Jun 2010 A1
20100168538 Keenan et al. Jul 2010 A1
20100168546 Kamath et al. Jul 2010 A1
20100190435 Cook et al. Jul 2010 A1
20100191082 Brister et al. Jul 2010 A1
20100191085 Budiman Jul 2010 A1
20100191472 Doniger et al. Jul 2010 A1
20100198034 Thomas et al. Aug 2010 A1
20100198142 Sloan et al. Aug 2010 A1
20100234710 Budiman et al. Sep 2010 A1
20100240975 Goode et al. Sep 2010 A1
20100274515 Hoss et al. Oct 2010 A1
20100277342 Sicurello Nov 2010 A1
20100312176 Hans-Martin et al. Dec 2010 A1
20100317958 Beck Dec 2010 A1
20110004276 Blair et al. Jan 2011 A1
20110024043 Boock et al. Feb 2011 A1
20110024307 Simpson et al. Feb 2011 A1
20110027127 Simpson et al. Feb 2011 A1
20110027453 Boock et al. Feb 2011 A1
20110027458 Boock et al. Feb 2011 A1
20110028815 Simpson et al. Feb 2011 A1
20110028816 Simpson et al. Feb 2011 A1
20110077490 Simpson et al. Mar 2011 A1
20110148905 Simmons et al. Jun 2011 A1
20110152637 Kateraas et al. Jun 2011 A1
20110213225 Bernstein Sep 2011 A1
20110257495 Hoss Oct 2011 A1
20110257895 Brauker et al. Oct 2011 A1
20110320130 Valdes et al. Dec 2011 A1
20110320167 Budiman Dec 2011 A1
20120078071 Bohm et al. Mar 2012 A1
20120108934 Valdes et al. May 2012 A1
20120161793 Satake Jun 2012 A1
20120173200 Breton et al. Jul 2012 A1
Foreign Referenced Citations (66)
Number Date Country
2143172 Jul 2005 CA
2396613 Mar 2008 CA
2413148 Aug 2010 CA
4401400 Jul 1995 DE
0098592 Jan 1984 EP
0127958 Dec 1984 EP
0320109 Jun 1989 EP
0353328 Feb 1990 EP
0390390 Oct 1990 EP
0396788 Nov 1990 EP
0286118 Jan 1995 EP
0724859 Aug 1996 EP
0678308 May 2000 EP
1048264 Nov 2000 EP
1292218 Mar 2003 EP
1077634 Jul 2003 EP
1568309 Aug 2005 EP
1666091 Jun 2006 EP
1703697 Sep 2006 EP
1704893 Sep 2006 EP
1897487 Nov 2009 EP
1897492 Nov 2009 EP
2113864 Nov 2009 EP
1897488 Dec 2009 EP
1681992 Apr 2010 EP
1448489 Aug 2010 EP
1971396 Aug 2010 EP
2201969 Mar 2011 EP
2153382 Feb 2012 EP
2284773 Feb 2012 EP
5353991 Nov 2013 JP
WO-1993006237 Apr 1993 WO
WO-1996025089 Aug 1996 WO
WO-1996035370 Nov 1996 WO
WO-1997033513 Sep 1997 WO
WO-1998035053 Aug 1998 WO
WO-1999056613 Nov 1999 WO
WO-2000049940 Aug 2000 WO
WO-2000059370 Oct 2000 WO
WO-2000074753 Dec 2000 WO
WO-2000078992 Dec 2000 WO
WO-2001052935 Jul 2001 WO
WO-2001054753 Aug 2001 WO
WO-2002016905 Feb 2002 WO
WO-2002058537 Aug 2002 WO
WO-2003076893 Sep 2003 WO
WO-2003082091 Oct 2003 WO
WO-2003085372 Oct 2003 WO
WO-2004047445 Jun 2004 WO
WO-2004061420 Jul 2004 WO
WO-2005040404 May 2005 WO
WO-2005041766 May 2005 WO
WO-2005045744 May 2005 WO
WO-2005089103 Sep 2005 WO
WO-2006024671 Mar 2006 WO
WO-2006032653 Mar 2006 WO
WO-2006051466 May 2006 WO
WO-2006064397 Jun 2006 WO
WO-2006079114 Jul 2006 WO
WO-2006118947 Nov 2006 WO
WO-2006124099 Nov 2006 WO
WO-2007007459 Jan 2007 WO
WO-2008086541 Jul 2008 WO
WO-2009086216 Jul 2009 WO
WO-2010077329 Jul 2010 WO
WO-2011022418 Feb 2011 WO
Non-Patent Literature Citations (56)
Entry
Cheyne, E. H., et al., “Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers”, Diabetes Technology & Therapeutics, vol. 4, No. 5, 2002, pp. 607-613.
Kuure-Kinsey, M., et al., “A Dual-Rate Kalman Filter for Continuous Glucose Monitoring”, Proceedings of the 28th IEEE, EMBS Annual International Conference, New York City, 2006, pp. 63-66.
Lo, B., et al., “Key Technical Challenges and Current Implementations of Body Sensor Networks”, Body Sensor Networks, 2005, pp. 1-5.
Lodwig, V., et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria”, Diabetes Technology & Therapeutics, vol. 5, No. 4, 2003, pp. 573-587.
Morbiducci, U, et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic Algorithms for Parameter Estimation”, Clinical Science, vol. 112, 2007, pp. 257-263.
Parker, R., et al., “Robust H∞ Glucose Control in Diabetes Using a Physiological Model”, AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549.
Rodriguez, N., et al., “Flexible Communication and Control Protocol for Injectable Neuromuscular Interfaces”, IEEE Transactions on Biomedical Circuits and Systems, vol. 1, No. 1, 2007, pp. 19-27.
PCT Application No. PCT/US2011/055177, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Apr. 18, 2013.
Mougiakakou, et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients”, Proceedings of the 2005 IEEE, 2005, pp. 298-301.
PCT Application No. PCT/US2011/055177, International Search Report and Written Opinion of the International Searching Authority dated Feb. 23, 2012.
Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526.
Aussedat, B., et al., “A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm”, Biosensors& Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1070.
Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, vol. 4, No. 1. 2002, pp. 25-33.
Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.
Brooks, S. L., et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987/88, pp. 45-56.
Cass, A. E., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.
Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.
El-Khatib, F. H, et al., “Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine”, Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.
Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.
Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.
Garg, S., et al., “Improvement in Glycemic Excusions with a Transcutaneous, Real-Time Continuous Glucose Sensor”, Diabetes Care, vol. 29. No. 1, 2006, pp. 44-50.
Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652.
Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719.
Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, p. 198.
Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, p. 250.
Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304.
Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549.
Lortz, J., et al., “What is Bluetooth? We Explain The Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74.
Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy”, Clinical Chemistry, vol. 45, No. 9. 1999, pp. 1651-1658.
McGarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense, Inc., 2001, 16 Pages.
McGarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376.
McKean, B. D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532.
Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346.
Pickup, J., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer”, Diabetologia, vol. 32, 1989, pp. 213-217.
Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272.
Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161.
Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241.
Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158.
Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322.
Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29. No. 13, 1996, pp. 2289-2308.
Schmtdtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299.
Shaw, G. W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406.
Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184.
Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20.
Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313.
Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210.
Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301.
Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Type Glucose Sensor”, The Lancet, 1982, pp. 1129-1131.
Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942.
Sternberg, R., et al., “Study and Development of Multilayer Needle-Type Enzyme-Based Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40.
Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261.
Turner, A., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, vol. 1, 1985, pp. 85-115.
Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137.
Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964.
Wilson, G. S., et al., “Progress Toward the Development of an Implantable Sensor for Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617.
EP, 11831644.7 Extended Search Report, dated Apr. 17, 2018.
Related Publications (1)
Number Date Country
20120088995 A1 Apr 2012 US
Provisional Applications (1)
Number Date Country
61391065 Oct 2010 US